SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-018686
Filing Date
2023-05-23
Accepted
2023-05-23 13:10:51
Documents
49
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 613334
2 ex31-1.htm EX-31.1 18150
3 ex31-2.htm EX-31.2 18146
4 ex32-1.htm EX-32.1 7373
5 ex32-2.htm EX-32.2 7470
  Complete submission text file 0001493152-23-018686.txt   3271576

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adxs-20230331.xsd EX-101.SCH 29339
7 XBRL CALCULATION FILE adxs-20230331_cal.xml EX-101.CAL 52232
8 XBRL DEFINITION FILE adxs-20230331_def.xml EX-101.DEF 80724
9 XBRL LABEL FILE adxs-20230331_lab.xml EX-101.LAB 241710
10 XBRL PRESENTATION FILE adxs-20230331_pre.xml EX-101.PRE 175745
43 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 404407
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 23947863
SIC: 2834 Pharmaceutical Preparations